Boston Analytical Implements Industry Leading LIMS System

Salem, NH (October 23, 2014) — Boston Analytical, the life sciences division of Alpha Analytical, recently announced that they have implemented the industry leading LabWare Inc.'s Laboratory Information Management System (LIMS)™ and Electronic Laboratory Notebook (ELN)™. Boston Analytical is a premier cGMP compliant, FDA & DEA registered, ISO/IEC-17025:2005 certified, pharmaceutical testing laboratory located in Salem, NH. The addition of the LabWare LIMS/ELN™ software has revolutionized the way that Boston Analytical does business.

Seen as the pharmaceutical industries' most technically advanced LIMS system since its introduction in to the market, LabWare's LIMS™ is a browser based laboratory and information management system that offers Boston Analytical the ability to meet cGMP requirements with full sample tracking, instrument management, auditing capabilities, report and sample scheduling, and more. LabWare's ELN™ is an experiment and workflow driven application that integrates seamlessly with the LIMS™ program. ELN™ allows Boston Analytical analysts electronically document their experiments including relevant scientific content and observations. Additional benefits of the LIMS/ELN product include:

  • All results are electronically captured from lab instruments ensuring correct and quality data.
  • Reports can be generated directly from easy to use applications such as Microsoft Word© and Excel©.
  • Boston Analytical is able to institutionalize compliance by implementing specifications and control limits across the company.
  • Standard operating procedures are accessible through ELN™, ensuring consistency throughout the organization.
  • Boston Analytical has been able to leverage industry best-practices by implementing pharma template standards.

"The biggest, and most important benefit of implementing the LabWare LIMS/ELN™ system is that it offers us the flexibility to accommodate new requests and implement new requirements with ease," states James Mich, Boston Analytical's General Manager. "This is essential in allowing us to offer our clients what they need. If a client has a new product or needs a new testing protocol, the LIMS/ELN™ system allows us the opportunity to implement new tests, procedures, or systems much quicker than we could before."

About Boston Analytical

Boston Analytical, the Life Sciences Division of Alpha Analytical, is a premier cGMP compliant, FDA & DEA registered, ISO Certified, pharmaceutical testing laboratory serving some of the most trusted institutional names worldwide. Founded in 1987, Boston Analytical provides a variety of the highest quality, analytical testing services to support CMC for Drug Development and Release Testing, including complete Stability Testing, Analytical Development Testing, and Microbiology Testing. Their testing services are used by Pharmaceutical, Biopharmaceutical and Medical Device companies worldwide. Boston Analytical is dedicated to customer satisfaction, high-quality, timely, and accurate analysis. From their methods, which are written in easy-to-understand, step-by-step formats to simplify method transfer, to their detailed documentation and reporting, Boston Analytical delivers the information their clients need with clarity and precision.

For more information on Boston Analytical's full range of Analytical, Stability & Storage and Microbiology testing services and capabilities, please contact Boston Analytical's sales team at 603-893-3758 or

About LabWare, Inc.

With worldwide headquarters in Wilmington, Delaware, LabWare Inc.'s products have been proven in a wide range of industries over a period of more than 20 years. Their sole focus is laboratory informatics and they develop, market, and support a single well planned suite of products. At the forefront of their Enterprise Laboratory Platform (ELP) are their flagship products, LabWare LIMS™ (Laboratory Information Management System) and LabWare ELN™ (Electronic Laboratory Notebook). For more information on LabWare, please visit their website

Download PDF of this announcement.